ImmunXperts, a Q² Solutions Company, offers services to support your drug development process, be it by mitigating risks through immunogenicity assessment.
Gosselies, Belgium
Joined May 2014
- Tweets58
- Following43
- Followers124
- Likes35
While touring the exhibit and posters through the conference, connect with Sofie Pattijn presenting our poster, # P067. This poster presentation follows a two day immunogenicity pre-conference training lead by our scientists, Sofie Pattijn and Chloe Ackaert.
PEGS Boston Conference and Expo starts this week. Cambridge Healthtech Institute launches this week with a series of workshops. This year's Introduction to Immunogenicity session will be presented by Sofie Pattijn and Chloe Ackaert. Full seminar agenda, bit.ly/3kkM2IL
Earlier this week Sofie Pattijn and Chloe Ackaert joined immunogenicity experts for a global event to address challenges, best practices, and strategies. We presented during the Prediction of Immunogenicity session.
In New Orleans, LA this weekend, scientists Thibaut Janss and Simon Lefevre will attend the American Association for Cancer Research Annual Meeting. Stop by the Q² Solutions Booth #3329 or meet with these experts during any of our four poster presentations.
Early development and candidate selection phases rely on a data driven approach to inform next stages of the therapeutic development cycle. Find out how utilization of in vitro bioassays is critical to understanding a molecule’s immunogenic potential, bit.ly/3JxbQMF
Thanks for all your support! Now that we’re a Nexelis company, stay in touch with ImmunXperts by following us on the @NexelisLabs page.
Now that we’re a part of Nexelis, we’ll no longer be posting here. Keep up with ImmunXperts’ latest news on the @NexelisLabs page!
ImmunXperts, a Q² Solutions Company retweeted
2 entreprises carolos misent en avant lors du #GPWEx 2020 !
@DreamWall_be a réalisé cette 1ère cérémonie virtuelle et @immunxperts récompensée !
Félicitations à eux et aux autres lauréats : @Sortlist , @Vinventions, @PharmatechDR, @ecosteryl & @KitoZyme 🌍 !
ImmunXperts, a Q² Solutions Company retweeted
👏Félicitations à @immunxperts, lauréat du🏆 Tremplin Grande Exportation🌎 de notre #GPWEx2020
Mais qui est #Immunexperts 🔬🧪💊🧫 ?
Découvrez-le en📽️>>> bit.ly/2J2MZ9A @PDELCOMMINETTE @WalloniaBe #NosEntreprisesOntDuTalent #WorldOfWallonia #SustainableWallonia
ImmunXperts, a Q² Solutions Company retweeted
It's #EuropeanResearchersNight! Make sure to check some of the cool science events organised across Europe today, especially the @meetme2night event in Milan, as @BactiVax will be there! Today @5pm CET & tomorrow @4pm we'll have interactive sessions on vaccine discovery. Link⬇️
This Post is from an account that no longer exists. Learn more
ImmunXperts, a Q² Solutions Company retweeted
3 days, 58 participants, 15 excellent ESR presentations, 6 scientific & training sessions, and our kick-off meeting was a success! Huge thanks to our speakers and to all who attended. #VaccinesWork
@mcclean_siobhan @HuebnerJohannes @REA_research @MSCActions @EU_H2020
ImmunXperts, a Q² Solutions Company retweeted
Our @BactiVax ESR kick-off meeting is on now! Happy to see the team together (even if just virtually) and looking foward to three busy days ahead 🤩. @mcclean_siobhan @HuebnerJohannes @REA_research @MSCActions @EU_H2020 #VaccinesWork
ImmunXperts, a Q² Solutions Company retweeted
Last but not least we have Lorenzo, our Project 15 Researcher! Lorenzo will be hosted by @immunxperts and will focus on developing in vitro assays to evaluate new vaccine candidates.
👨🔬bit.ly/2VChI0D @LorenzoBossi5
#VaccinesWork @REA_research @mcclean_siobhan @MSCActions
ImmunXperts, a Q² Solutions Company retweeted
Time to come together, leverage every resource for the greater good!
Nexelis, @ImmunXperts and @PHE_uk experts are working together on speeding up the development of vaccines and therapeutics xtalks.com/webinars/the-sars… via @xtalks
ImmunXperts, a Q² Solutions Company retweeted
La biotech belge ImmunXperts rachetée par le canadien Nexelis bit.ly/2ImLEXg Par @GossetOlivier1 | @immunxperts #Nexelis #biotech
